Literature DB >> 11880426

Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay.

Leen-Jan van Doorn1, Wim Quint, Bernhard Kleter, Anco Molijn, Brigitte Colau, Marie-Thérèse Martin, Norah Torrez-Martinez, Cheri L Peyton, Cosette M Wheeler.   

Abstract

A comparison of two PCR-based human papillomavirus (HPV) DNA detection and genotyping systems (PGMY LBA and SPF(10) LiPA) was conducted in two laboratories. Both systems are based on broad-spectrum PCR for the detection of HPV DNA, followed by reverse hybridization with type-specific probes. A total of 400 selected cervical scrape specimens in PreservCyt solution (55% normal cytology, 18% atypical squamous cells of unknown significance, 14.8% low-grade squamous intraepithelial lesions [SIL], and 12.5% high-grade SIL) were tested for the presence of HPV DNA. In this selected group of specimens, the overall agreement between the two methods for the detection of any HPV DNA was high (kappa = 0.859). When the 20 common HPV genotypes identified by both methods were considered (HPV types 6, 11, 16, 18, 31, 33, 35, 39, 40, 42, 45, 51, 52, 53, 54, 56, 58, 59, 66, and 68), compatible genotype-specific results were observed in 96.5% of the samples, even when multiple HPV genotypes were present. However, for some specific HPV genotypes, there were significant differences in HPV detection by the two methods. PGMY LBA detected more HPV type 42 (P = 0.002), HPV type 56 (P = 0.039), and HPV type 59 (P < 0.001), whereas SPF(10) LiPA detected more HPV type 31 (P < 0.001) and HPV type 52 (P = 0.031). For the remaining genotypes, including HPV types 16 and 18, the results obtained by the two methods were not significantly different. In general, both genotyping methods are highly suitable for clinical and epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11880426      PMCID: PMC120246          DOI: 10.1128/JCM.40.3.979-983.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Interlaboratory agreement of different human papillomavirus DNA detection and typing assays in cervical scrapes.

Authors:  I Nindl; M Jacobs; J M Walboomers; C J Meijer; H Pfister; U Wieland; T Meyer; E Stockfleth; R Klaes; M von Knebel Doeberitz; A Schneider; M Duerst
Journal:  Int J Cancer       Date:  1999-05-17       Impact factor: 7.396

3.  A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings.

Authors:  M V Jacobs; P J Snijders; A J van den Brule; T J Helmerhorst; C J Meijer; J M Walboomers
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

4.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

5.  Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective.

Authors:  T Yamada; M M Manos; J Peto; C E Greer; N Munoz; F X Bosch; C M Wheeler
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

6.  Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method.

Authors:  P E Gravitt; C L Peyton; R J Apple; C M Wheeler
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

7.  Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus.

Authors:  B Kleter; L J van Doorn; L Schrauwen; A Molijn; S Sastrowijoto; J ter Schegget; J Lindeman; B ter Harmsel; M Burger; W Quint
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

8.  Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study.

Authors:  M A Nobbenhuis; J M Walboomers; T J Helmerhorst; L Rozendaal; A J Remmink; E K Risse; H C van der Linden; F J Voorhorst; P Kenemans; C J Meijer
Journal:  Lancet       Date:  1999-07-03       Impact factor: 79.321

9.  Natural history of cervicovaginal papillomavirus infection in young women.

Authors:  G Y Ho; R Bierman; L Beardsley; C J Chang; R D Burk
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

10.  Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses.

Authors:  B Kleter; L J van Doorn; J ter Schegget; L Schrauwen; K van Krimpen; M Burger; B ter Harmsel; W Quint
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

View more
  36 in total

1.  Bead-based multiplex genotyping of 58 cutaneous human papillomavirus types.

Authors:  K M Michael; O Forslund; O Bacevskij; T Waterboer; I G Bravo; M Pawlita; M Schmitt
Journal:  J Clin Microbiol       Date:  2011-08-10       Impact factor: 5.948

2.  Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test.

Authors:  François Coutlée; Danielle Rouleau; Patrick Petignat; Georges Ghattas; Janet R Kornegay; Peter Schlag; Sean Boyle; Catherine Hankins; Sylvie Vézina; Pierre Coté; John Macleod; Hélène Voyer; Pierre Forest; Sharon Walmsley; Eduardo Franco
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  Evaluation of different techniques for identification of human papillomavirus types of low prevalence.

Authors:  Ivan Sabol; Martina Salakova; Jana Smahelova; Michal Pawlita; Markus Schmitt; Nina Milutin Gasperov; Magdalena Grce; Ruth Tachezy
Journal:  J Clin Microbiol       Date:  2008-03-05       Impact factor: 5.948

4.  Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with the linear array HPV genotyping PCR assay and influence of DNA extraction method on HPV detection.

Authors:  Christine C Roberts; Ryan Swoyer; Janine T Bryan; Frank J Taddeo
Journal:  J Clin Microbiol       Date:  2011-02-23       Impact factor: 5.948

5.  Human papillomavirus in high-grade cervical lesions: Austrian data of a European multicentre study.

Authors:  Lucia Rössler; Olaf Reich; Reinhard Horvat; Sabrina Collas de Souza; Katsyarina Holl; Elmar A Joura
Journal:  Wien Klin Wochenschr       Date:  2013-09-17       Impact factor: 1.704

6.  Detection and typing of human papillomavirus by e6 nested multiplex PCR.

Authors:  K Sotlar; D Diemer; A Dethleffs; Y Hack; A Stubner; N Vollmer; S Menton; M Menton; K Dietz; D Wallwiener; R Kandolf; B Bültmann
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

7.  High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil.

Authors:  José E Levi; Bernhard Kleter; Wim G V Quint; Maria C S Fink; Cynthia L M Canto; Regina Matsubara; Iara Linhares; Aluísio Segurado; Bart Vanderborght; José Eluf Neto; Leen-Jan Van Doorn
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

8.  The laboratory diagnosis of genital human papillomavirus infections.

Authors:  François Coutlée; Danielle Rouleau; Alex Ferenczy; Eduardo Franco
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-03       Impact factor: 2.471

9.  Validation of human papillomavirus genotyping by signature DNA sequence analysis.

Authors:  Sin Hang Lee; Veronica S Vigliotti; Jessica S Vigliotti; Suri Pappu
Journal:  BMC Clin Pathol       Date:  2009-05-22

10.  Signature sequence validation of human papillomavirus type 16 (HPV-16) in clinical specimens.

Authors:  Sin Hang Lee; Veronica S Vigliotti; Suri Pappu
Journal:  J Clin Pathol       Date:  2009-10-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.